Race Against Time: Addressing the Unmet Needs of Patients with HER2-Positive Metastatic Breast Cancer
Over the last 20 years, there has been remarkable progress in the development of the therapies for human epidermal growth factor receptor-2 (HER2)-positive breast cancer (BC). Targeted treatment agents, such as trastuzumab, pertuzumab, lapatinib, and trastuzumab emtansine (T-DM1), are currently reco...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2020-11-01
|
| Series: | European Medical Journal Oncology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/oncology/article/race-against-time-addressing-the-unmet-needs-of-patients-with-her2-positive-metastatic-breast-cancer/ |